We invest in early-stage companies, founded on innovative research-based technologies within pharma and medtech, with compelling value propositions serving unmet medical needs. We look for well-defined development plans with clear value inflection points, enabling robust returns on investment. 

We invest in leading early stage science and technology based companies with technologies that can make the world a better place and accelerate the transition to a 100% renewable energy system. We look for exceptional entrepreneurs and breakthrough innovations that may have an disruptive impact on industries and markets and create value for individuals, society, industry and investors.